Stocks
Intellia Therapeutics (NTLA) P/E US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -31.3 | 0.00 | 0.00 | -2.22 | -2.36 | -4.71 | ||
| Changes by years, y/y, % | +38% | -100% | +6% | -36.4% | |||||
Intellia Therapeutics. P/E
Intellia Therapeutics. P/E, changes, %
Intellia Therapeutics (NTLA) P/E US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/E | ? | -1.40 | -2.03 | -4.27 | -2.36 | -3.85 | -4.71 | |
| Changes by years, y/y, % | +7% | +3% | +175% | |||||
| Changes by quarters, q/q, % | -39% | +45% | +111% | -45% | +63% | |||
